What does OCULUS OOGARTSEN do?

OCULUS OOGARTSEN is a specialist medical practice in Ieper. Private Limited, started on 4 July 2022, 1 establishment.

What is the address of OCULUS OOGARTSEN?

The registered office of OCULUS OOGARTSEN is located at D'hondtstraat 65, 8900 Ieper.

Is OCULUS OOGARTSEN still active?

Yes. According to the CBE (29 October 2026) OCULUS OOGARTSEN is active, legal situation “Normale toestand”, started on 4 July 2022.

Is OCULUS OOGARTSEN registered on Peppol?

Yes, OCULUS OOGARTSEN is registered on the Peppol network with ID 0208:0787990584.

What is the enterprise number of OCULUS OOGARTSEN?

The enterprise number of OCULUS OOGARTSEN is BE0787990584.

When was OCULUS OOGARTSEN founded?

OCULUS OOGARTSEN was founded on 4 July 2022.

Who are the directors of OCULUS OOGARTSEN?

According to the 2025 annual accounts, the directors of OCULUS OOGARTSEN are: Sofie Ghekiere, Johan Blanckaert, Vincent Walgrave, Evelyne Mulliez.

Is OCULUS OOGARTSEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 July 2022; 4 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account.

How much profit did OCULUS OOGARTSEN make in 2025?

OCULUS OOGARTSEN posted a profit after taxes of € 119,253 in financial year 2025.

What is the revenue of OCULUS OOGARTSEN?

As a small company, OCULUS OOGARTSEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,486,284.

OCULUS OOGARTSEN (Private Limited) - Ieper - BE0787990584

Dossier OCULUS OOGARTSEN, printed on 29 October 2026 from databakkes.be/en/0787990584/oculus-oogartsen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 39 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

OCULUS OOGARTSEN from Ieper, company number BE0787990584, closed financial year 2025 with a result of € 119,253 after tax. For that financial year OCULUS OOGARTSEN recorded a gross margin of € 1.5 million and equity of € 519,296. Compared with financial year 2024, the result moved from € 120,002 to € 119,253. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 519,296

▲ 30% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 119,253

▼ 1% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 589,028

▲ 82% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 479,296.

People and assets in 2025

Wage cost

€ 384,241

▲ 5% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 16,748

▼ 55% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 3.5 million

▼ 19% vs 2024

€ 929,491 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 375,815

▲ 37% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 42,910

▲ 3% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 474,552 Gross margin 2022: € 474,552 First fiscal year in the series	€ 1,484,359 Gross margin 2023: € 1,484,359 ▲ 213% vs 2022 (€ 474,552) Favourable step	€ 1,457,990 Gross margin 2024: € 1,457,990 ▼ 2% vs 2023 (€ 1,484,359) Unfavourable step	€ 1,486,284 Gross margin 2025: € 1,486,284 ▲ 2% vs 2024 (€ 1,457,990) Favourable step	▲ 2%
Profit after taxes	€ 120,042 Profit after taxes 2022: € 120,042 First fiscal year in the series	€ 120,000 Profit after taxes 2023: € 120,000 Unchanged (€ 120,042) Unfavourable step	€ 120,002 Profit after taxes 2024: € 120,002 Unchanged (€ 120,000) Favourable step	€ 119,253 Profit after taxes 2025: € 119,253 ▼ 1% vs 2024 (€ 120,002) Unfavourable step	▼ 1%
Equity	€ 160,042 Equity 2022: € 160,042 First fiscal year in the series	€ 280,042 Equity 2023: € 280,042 ▲ 75% vs 2022 (€ 160,042) Favourable step	€ 400,043 Equity 2024: € 400,043 ▲ 43% vs 2023 (€ 280,042) Favourable step	€ 519,296 Equity 2025: € 519,296 ▲ 30% vs 2024 (€ 400,043) Favourable step	▲ 30%
Total debts	€ 6,968,040 Total debts 2022: € 6,968,040 First fiscal year in the series	€ 6,337,397 Total debts 2023: € 6,337,397 ▼ 9% vs 2022 (€ 6,968,040) Favourable step	€ 6,164,040 Total debts 2024: € 6,164,040 ▼ 3% vs 2023 (€ 6,337,397) Favourable step	€ 5,444,175 Total debts 2025: € 5,444,175 ▼ 12% vs 2024 (€ 6,164,040) Favourable step	▼ 12%
Cash	€ 236,247 Cash 2022: € 236,247 First fiscal year in the series	€ 427,848 Cash 2023: € 427,848 ▲ 81% vs 2022 (€ 236,247) Favourable step	€ 324,529 Cash 2024: € 324,529 ▼ 24% vs 2023 (€ 427,848) Unfavourable step	€ 589,028 Cash 2025: € 589,028 ▲ 82% vs 2024 (€ 324,529) Favourable step	▲ 82%
Retained profit	€ 120,042 Retained profit 2022: € 120,042 First fiscal year in the series	€ 240,042 Retained profit 2023: € 240,042 ▲ 100% vs 2022 (€ 120,042) Favourable step	€ 360,043 Retained profit 2024: € 360,043 ▲ 50% vs 2023 (€ 240,042) Favourable step	€ 479,296 Retained profit 2025: € 479,296 ▲ 33% vs 2024 (€ 360,043) Favourable step	▲ 33%
Bank debt	€ 5,799,571 Bank debt 2022: € 5,799,571 First fiscal year in the series	€ 5,122,599 Bank debt 2023: € 5,122,599 ▼ 12% vs 2022 (€ 5,799,571) Favourable step	€ 4,238,621 Bank debt 2024: € 4,238,621 ▼ 17% vs 2023 (€ 5,122,599) Favourable step	€ 3,451,390 Bank debt 2025: € 3,451,390 ▼ 19% vs 2024 (€ 4,238,621) Favourable step	▼ 19%
Balance sheet total	€ 7,128,081 Balance sheet total 2022: € 7,128,081 First fiscal year in the series	€ 6,617,439 Balance sheet total 2023: € 6,617,439 ▼ 7% vs 2022 (€ 7,128,081) Unchanged	€ 6,564,084 Balance sheet total 2024: € 6,564,084 ▼ 1% vs 2023 (€ 6,617,439) Unchanged	€ 5,963,471 Balance sheet total 2025: € 5,963,471 ▼ 9% vs 2024 (€ 6,564,084) Unchanged	▼ 9%

Key figures of OCULUS OOGARTSEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to OCULUS OOGARTSEN?

What happened at OCULUS OOGARTSEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 119,253 (▼ 1% vs 2024). filed late Source: NBB ↗
Jul 4, 2022 New establishment in Ieper. KBO
Jul 4, 2022 Start of the company according to the CBE. KBO
2022 Sofie Ghekiere became a director. NBB
2022 Johan Blanckaert became a director. NBB
2022 Vincent Walgrave became a director. NBB
2022 Evelyne Mulliez became a director. NBB

In short

From € 120,042 profit in 2022 to € 119,253 profit in 2025.

Paid € 151,704 in corporate taxes since 2022.

Best year ever: 2022, with € 120,042 profit.

Original PDFs at the National Bank ↗

Management

Sofie Ghekiere Johan Blanckaert Vincent Walgrave Evelyne Mulliez

OCULUS MD

Blandes

IMMOVISION

OCULUS OOGARTSEN

Behind OCULUS OOGARTSEN are Sofie Ghekiere, Johan Blanckaert, Vincent Walgrave and Evelyne Mulliez. Sofie Ghekiere is also behind OCULUS MD and Dr. Sofie Ghekiere - Oftalmologie. Johan Blanckaert is also behind Blandes, Blanckaert MD, IMMOVISION and OCULUS MD. Evelyne Mulliez is also behind IMMOVISION, OCULUS MD and Dr. E. MULLIEZ.

Directors

According to the 2025 annual accounts

Sofie Ghekiere

Statutaire Bestuurder

Also active at: OCULUS MD, Dr. Sofie Ghekiere - Oftalmologie

since 2022

Johan Blanckaert

Statutaire Bestuurder

Also active at: Blandes, Blanckaert MD, IMMOVISION, OCULUS MD

since 2022

Vincent Walgrave

Statutaire Bestuurder

since 2022

Evelyne Mulliez

Statutaire Bestuurder

Also active at: IMMOVISION, OCULUS MD, Dr. E. MULLIEZ

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

D'hondtstraat 65

8900 Ieper

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Vrienden van de Muziekacademie Ieper

Ortholinto

€ -12,247 gross margin · 2026

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0787.990.584
VAT number: BE 0787.990.584
Registered office: D'hondtstraat 65, 8900 Ieper
Names & denominations: OCULUS OOGARTSEN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 4 July 2022
Peppol: Active · Active since 17 Feb 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗

OCULUS OOGARTSEN

Warning lights

Financials

What happened to OCULUS OOGARTSEN?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions